STOCK TITAN
  1. Home
  2. News
  3. OLK

Olink Holding AB (publ) American Depositary Shares - OLK STOCK NEWS

Welcome to our dedicated news page for Olink Holding AB (publ) American Depositary Shares (Ticker: OLK), a resource for investors and traders seeking the latest updates and insights on Olink Holding AB (publ) American Depositary Shares.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Olink Holding AB (publ) American Depositary Shares's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Olink Holding AB (publ) American Depositary Shares's position in the market.

News
Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024
Rhea-AI Summary
The Annual General Meeting of Olink Holding AB (publ) on April 19, 2024, adopted resolutions including approving balance sheets, remuneration to the Board of Directors, re-election of Board Members and auditor, incentive programs, and authorization for new share issues.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.73%
Tags
none
-
News
Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease
Rhea-AI Summary
Olink Holding AB (Nasdaq: OLK) launches a data library with 300,000 protein-disease risk associations from UK Biobank, aiding researchers in understanding 106 human diseases. The library, available on Olink Insight, provides insights into protein effects on disease risk and offers a tool for biomarker discovery. A technical webinar on April 24, 2024, will showcase leveraging this data for research.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.04%
Tags
none
-
News
Olink reports fourth quarter and full year 2023 financial results
Rhea-AI Summary
Olink Holding AB (OLK) reported strong financial results for the fourth quarter of 2023, with revenue reaching $68.6 million, showing an 18% year-over-year growth. Full-year revenue totaled $169.6 million, marking a 21% increase. The company ended the quarter with a cash balance of $121 million. Thermo Fisher Scientific's proposed acquisition of Olink is expected to be completed by mid-2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.49%
Tags
earnings
News
Olink publishes 2023 annual report
Rhea-AI Summary
Olink Holding AB (OLK) releases its Annual Report for 2023, accessible on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.49%
Tags
none
-
News
Notice to attend the Annual General Meeting of Olink Holding AB (publ)
Rhea-AI Summary
Olink Holding AB announces its Annual General Meeting to be held on April 19, 2024, in Uppsala, Sweden. Shareholders must register by April 15, 2024, to attend the meeting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.08%
Tags
conferences
-
News
Olink announces change of date for Annual General Meeting
Rhea-AI Summary
Olink Holding AB reschedules its 2024 Annual General Meeting to April 19th, 2024, in Uppsala, Sweden.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.85%
Tags
none
News
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2023 Results
Rhea-AI Summary
Thermo Fisher Scientific Inc. (TMO) reported Q4 revenue of $10.89 billion, 5% lower than the previous year. Full-year revenue was $42.86 billion, also 5% lower. GAAP diluted EPS for Q4 was $4.20, 5% higher than last year, with an adjusted EPS of $5.67, also 5% higher. The company strengthened its industry leadership, launched innovative products, and expanded its global presence. Thermo Fisher executed its capital deployment strategy, completed key acquisitions, and returned $3.5 billion to shareholders. The company initiated a guidance range for full year 2024 with revenue of $42.1 billion to $43.3 billion and adjusted EPS of $20.95 to $22.00.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.29%
Tags
earnings
-
News
Madryn Asset Management Issues Presentation Detailing Why SomaLogic Shareholders Should Vote “AGAINST” the Value-Destructive and Deeply Flawed Proposed Merger with Standard BioTools
Rhea-AI Summary
Madryn Asset Management, LP (Madryn) urges SomaLogic Inc. (Nasdaq: SLGC) shareholders to vote 'AGAINST' the proposed merger with Standard BioTools Inc. (Nasdaq: LAB). Madryn holds approximately 4.2% of SomaLogic's outstanding common stock and has published a list of key questions shareholders should ask the Board of Directors regarding the Proposed Merger.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.69%
Tags
acquisition
-
News
Olink reports third quarter 2023 financial results
Rhea-AI Summary
Olink Holding AB (publ) (Nasdaq: OLK) announced unaudited financial results for Q3 2023, with revenue of $44.2 million, a 39% YoY growth. Explore customer installations reached 87, and Signature Q100 placements reached 153. Q3 net loss was $(1.8) million, with adjusted EBITDA of $2.0 million. Olink exited Q3 2023 with a cash balance of $130 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.83%
Tags
earnings
News
Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics
Rhea-AI Summary
Olink Holding AB announces that Novogene Asia Pacific Middle East and Africa has adopted the Olink Explore HT platform for next-generation proteomics technology. This partnership enhances Novogene's research services offerings and allows scientists to measure over 5,400 proteins with high specificity and sensitivity. The integration of Olink technology will provide actionable data and insights into disease biology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.16%
Tags
none
Stock OLK logo
Olink Holding AB (publ) American Depositary Shares

Nasdaq:OLK

OLK Rankings

#1600 Ranked by Market Cap
#587 Ranked by Stock Gains
N/A Ranked by Dividends

OLK Stock Data

2.90B
40.67M
66.62%
34.6%
1.87%
Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
United States of America
Uppsala

About OLK

Olink Holding AB provides accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients.